Fractional flow reserve to determine the appropriateness of percutaneous renal artery intervention in atherosclerotic renovascular hypertension patients: a randomized trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Jianping Li

Peking University First Hospital, Beijing (China)

4 More presentations in this session

Presentation thumbnail

Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.

Doctor M. Heradien (Kuils River, ZA)

Presentation thumbnail

Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results from the SPRINT Randomized Trial

Doctor Y. Xiao (Changsha, CN)

Presentation thumbnail

A machine learning algorithm for personalizing intensive blood pressure treatment: derivation from SPRINT/ACCORD-BP trials and validation in CRHCP, a pragmatic implementation trial

Professor Y. Sun (Shenyang, CN)

Presentation thumbnail

Long-term outcomes of intensive blood-pressure control in older patients with hypertension: final six-year results of the STEP trial

Doctor Q. Song (Beijing, CN)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies on hypertension

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Blood pressure should be lowered as low as possible - discussion

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

Opening: tackling the unmet need in hypertension care

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources